Christiansen publikationsverzeichnis 08.201

Publikationsverzeichnis Prof. Dr. med. Hans Christiansen (Stand 08/2011)
1. Originalarbeiten
(insgesamt 71 Originalarbeiten, davon 34 als verantwortlicher Erst- oder Letztautor,
kumulativer Impact-Faktor [gelistete Journale]: 218,984;
durchschnittlicher Impact-Faktor [gelistete Journale]: 3,174;
die angegebenen Impact-Faktoren beziehen sich jeweils auf das Jahr des Erscheinens,
bei den Arbeiten aus 2011 ist der Impact-Faktor von 2010 angegeben)
1. Schirmer AM, Mergler CPN, Rave-Fränk M, Herrmann MK, Hennies S, Gaedcke J, Conradi LC, Jo P, Beissbarth T, Hess CF, Becker H, Ghadimi M, Brockmöller J, Christiansen H*, Wolff HA“ (2011): Acute toxicity of radiochemotherapy in rectal cancer
patients: A risk particularly for carriers of the TGFB1 Pro25 allele. (Int J Radiat Oncol Biol Phys, im Druck) *equal senior authorship
2. Wolff HA, Conradi LC, Schirmer M, Beissbarth T, Sprenger T, Rave-Fränk M, Hennies S, Hess CF, Becker H, Christiansen H*, Liersch T* (2011): Gender-specific acute
organ toxicity during intensified preoperative radiochemotherapy for rectal cancer. The Oncologist 16, 621-631 *equal senior authorship
3. Krause P, Wolff HA, Rave-Frank M, Schmidberger H, Becker H, Hess CF, Christiansen H*, Koenig S* (2011): Fractionated external beam radiotherapy as a
suitable preparative regimen for hepatocyte transplantation following partial hepatectomy. Int J Radiat Oncol Biol Phys 80, 1214-1219 *equal senior authorship
4. Koenig S, Yuan Q, Krause P, Christiansen H, Rave-Fraenk M, Kafert-Kasting S,
Kriegbaum H, Schneider A, Ott M, Meyburg J (2011): Regional transient portal ischemia and irradiation as preparative regimen for hepatocyte transplantation. Cell Transplant 5. Bogdanova N, Sokolenko AP, Iyevleva AG, Abysheva SN, Blaut M, Bremer M, Christiansen H, Rave-Fränk M, Dörk T, Imyanitov EN (2011): PALB2 mutations in
German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat 6. Wolff HA, Raus I, Jung K, Schüler P, Herrmann MKA, Hennies S, Vorwerk H, Hille A, Hess CF, Christiansen H (2011): High-grade acute organ toxicity as positive
prognostic factor in primary radiochemotherapy for anal carcinoma. Int J Radiat Oncol 7. Uhmann A, van den Brandt J, Dittmann K, Heß I, Dressel K, Binder C, Lühder F, Christiansen H, Fassnacht M, Bhandoola A, Wienands J, Reichardt HM, Hahn H
(2011): T cell development critically depends on prethymic stromal Patched expression. 8. Wolff HA, Daldrup B, Jung K, Overbeck T, Hennies S, Matthias C, Hess CF, Roedel RMW, Christiansen H (2011): High-grade acute organ toxicity as positive prognostic
factor in adjuvant radio(chemo)therapy for locally advanced head and neck cancer. 9. Wolff HA, Rolke D, Rave-Fränk M, Schirmer M, Eicheler W, Doerfler A, Hille A, Hess CF, Matthias C, Rödel RMW, Christiansen H (2011): Analysis of chemokine and
chemokine receptor expression in Squamous Cell Carcinoma of the Head and Neck (SCCHN) cell lines. Radiat Environ Biophys 50, 145-154 10. Schirmer M, Brockmöller J, Rave-Fränk M, Virsik P, Wilken B, Kühnle E, Campean R, Hoffmann AO, Müller K, Goetze RG, Neumann, M, Janke JH, Nasser F, Wolff HA, Ghadimi BM, Schmidberger H, Hess CF, Christiansen H, Hille A (2011): A putatively
functional haplotype in the gene encoding transforming growth factor-beta1 (TGFβ1) as a potential biomarker for radiosensitivity. Int J Radiat Oncol Biol Phys 79, 866-874 11. Wolff HA, Hennies S, Herrmann MKA, Rave-Fränk M, Eickelmann D, Virsik P, Jung K, Schirmer M, Ghadimi M, Hess CF, Hermann RM, Christiansen H (2011): Comparison
of micronucleus- and chromosome aberration technique for the documentation of cytogenetic damage in radiochemotherapy treated patients with rectal cancer. 12. Wolff HA, Wagner DM, Christiansen H, Hess CF, Vorwerk H (2010): Single fraction
radiosurgery using Rapid Arc for treatment of intracranial targets. Radiat Oncol 5, 77 13. Krause P, Rave-Fränk M, Wolff HA, Becker H, Christiansen H, Koenig S (2010): Liver
sinusoidal endothelial and biliary cell repopulation following irradiation and partial hepatectomy. World J Gastroenterol 16, 3928-3935 14. Wolff HA, Bosch J, Jung K, Overbeck T, Hennies S, Matthias C, Hess CF, Roedel RMW, Christiansen H (2010): High-grade acute organ toxicity as positive prognostic
factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck 15. Hille A, Grüger S, Christiansen H, Wolff HA, Volkmer B, Lehmann J, Dörr W, Rave-
Fränk M (2010): Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro. Radiat Environ Biophys 49, 261-270 16. Dähn D, Martell J, Vorwerk H, Hess CF, Becker H, Jung K, Hilgers R, Wolff HA, Hermann RM, Christiansen H (2010): Determine irradiated lung volumes perioperative
morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer? Int J Radiat Oncol Biol Phys 77, 44-52 17. Sprenger T, Rothe H, Jung K, Christiansen H, Conradi LC, Ghadimi BM, Becker H,
Liersch T (2010): Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification? World 18. Malik IA, Moriconi F, Sheikh N, Naz N, Khan S, Dudas J, Mansuroglu T, Hess CF, Rave-Fränk, Christiansen H, Ramadori G (2010): Single-dose gamma-irradiation
induces up-regulation of chemokinegene expression and recruitment of granulocytes into the portal area but not into other regions of rat hepatic tissue. Am J Pathol 176, 19. Roedel RMW, Matthias C, Wolff HA, Schindler P, Aydin T, Christiansen H (2010):
Transoral laser microsurgery for recurrence after primary radiotherapy of early glottic 20. Roedel RMW, Matthias C, Wolff HA, Christiansen H (2010): Repeated Transoral Laser
Microsurgery for Early and Advanced Recurrence after Primary Laser Resection of Early Glottic Cancer. Auris Nasus Larynx 37, 340-346 21. Wolff HA, Gaedcke J, Jung K, Hermann RM, Rothe H, Schirmer M, Liersch T, Herrmann MKA, Hennies S, Rave-Fränk M, Hess CF, Christiansen H (2010): High-
grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathological tumour regression in multimodal treatment of locally advanced rectal cancer Strahlenther Onkol 186, 30-35 22. Wolff HA, Rödel RMW, Gunawan B, Overbeck T, Herrmann MKA, Hennies S, Hille A, Vorwerk H, Matthias C, Hess CF, Christiansen H (2010): Nasopharyngeal carcinoma
in adults – treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas. J Cancer Res Clin Oncol 136, 89-96 23. Wagner D, Christiansen H, Wolff HA, Vorwerk H (2009): Radiotherapy of malignant
gliomas: Comparison of a volumetric single arc technique (RapidArc), a dynamic intensity modulated technique and a 3D conformal technique. Radiother Oncol 93, 593- 24. Vorwerk H, Wagner D, Seitz B, Christiansen H, Wolff HA, Hess CF (2009):
Overestimation of low-dose radiation in intensity modulated radiotherapy with sliding- window technique. Strahlenther Onkol 185, 821-829 25. Kertesz T, Herrmann MK, Zapf A, Christiansen H, Hermann RM, Pradier O,
Schmidberger H, Hess CF, Hille A (2009): Effect of a Prostaglandin - Given Rectally for Prevention of Radiation-Induced Acute Proctitis - on Late Rectal Toxicity: Results of a Phase III Randomized, Placebo-Controlled, Double-Blind Study. Strahlenther Onkol 26. Hille A, Rave-Fränk M, Christiansen H, Herrmann MKA, Kertesz T, Hermann RM,
Wolff HA, Schirmer M, Hess CF, Ramadori G (2009): Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study. Scand J Gastroenterol 44, 939-946 27. Rödel RMW, Matthias C, Blomeyer B, Wolff H, Jung K, Christiansen H (2009): Impact
of distant metastasis in patients with cervical lymph node metastases from cancer of unknown primary site. Ann Otol Rhinol Laryngol 118, 662-669 28. Moriconi F, Malik I, Ahmad G, Dudas J, Rave-Fränk M, Vorwerk H, Hille A, Hess CF, Ramadori G, Christiansen H (2009): Effect of irradiation on gene expression of rat liver
adhesion molecules: in vivo and in vitro studies. Strahlenther Onkol 185, 460-468 29. Sennhenn-Kirchner S, Freund F, Grundmann S, Martin A, Borg-von Zepelin M, Christiansen H, Wolff HA, Jacobs HG (2009): Dental therapy before and after
radiotherapy-an evaluation on patients with head and neck malignancies. Clin Oral 30. Herrmann MK, Gsänger T, Strauss A, Kertesz T, Wolff HA, Christiansen H, Vorwerk H,
Hess CF, Hille A (2009): The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment. 31. Qeseraku B, Dudas J, Rave-Fränk M, Hess CF, Ramadori G, Saile B, Christiansen H
(2009): Effect of TNF-α and irradiation alone or in combination on the viability of hepatocellular and biliary adenocarcinoma cell lines in vitro. Liver Int 29, 910-921 32. Wolff HA, Overbeck T, Roedel RM, Hermann RM, Herrmann MKA, Kertesz T, Vorwerk H, Hille A, Matthias C, Hess CF, Christiansen H (2009): Toxicity of daily low dose
cisplatin in radiochemotherapy for locally advanced head and neck cancer. J Cancer 33. Koenig S, Krause P, Seif Amir Hosseini A, Dullin C, Rave-Fränk M, Kimmina S, Hermann RM, Hess CF, Becker H, Christiansen H (2009): Non-invasive imaging of
liver repopulation following hepatocyte transplantation. Cell Transplant 18, 69-78 34. Vorwerk H, Beckmann G, Bremer M, Degen M, Dietl B, Fietkau R, Gsänger T, Hermann RM, Herrmann MKA, Höller U, van Kampen M, Körber W, Maier B, Martin T, Metz M, Richter R, Siekmeyer B, Steder M, Wagner D, Hess CF, Weiss E, Christiansen H
(2009): The delineation of target volumes for radiotherapy of lung cancer patients. 35. Olthoff A, Ewen A, Wolff HA, Hermann RM, Vorwerk H, Hille A, Rödel R, Hess CF, Steiner W, Pradier O, Christiansen H (2009): Organ function and quality of life after
transoral laser microsurgery and adjuvant radiotherapy for locally advanced laryngeal 36. Vorwerk H, Liersch T, Rothe H, Ghadimi M, Christiansen H, Hess CF, Hermann RM
(2009): Gold markers for tumor localisation and target volume delineation in radiotherapy for rectal cancer. Strahlenther Onkol 185, 127-133 37. Guerleyen H*, Christiansen H*, Tello K, Dudas J, Hermann RM, Rave-Fränk M, Hess
CF, Ramadori G, Saile B (2009): Irradiation leads to sensitization of hepatocytes to TNF-alpha-mediated apoptosis by upregulation of IkappaB expression. Radiat Environ Biophys 48, 85-94 *equal first authorship
38. Roedel R, Christiansen H, Mueller RM, Matthias C (2009): Transoral Laser
Microsurgery for Carcinoma in Situ of the Glottic Larynx. ORL J Otorhinolaryngol Relat 39. Nitsche M, Horstmann O, Christiansen H, Hermann RM, Hess CF, Becker H, Pradier
O, Schmidberger H (2008): Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon in pancreatic and periampullary cancer: Results of a feasibility study. Cancer Impact-Faktor: Im Jahr 2008 nicht gelistet 40. Hille A, Herrmann MKA, Kertesz T, Christiansen H, Hermann RM, Pradier O,
Schmidberger H, Hess CF (2008): Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis – a prospective evaluation. Strahlenther Onkol 184, 686-692 41. Hille A, Schmidt-Giese E, Hermann RM, Herrmann MK, Rave-Fränk M, Schirmer M, Christiansen H, Hess CF, Ramadori G (2008): A prospective study of faecal
calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment. Scand J Gastroenterol 43, 52-58 42. Martin A, Jäckel MC, Christiansen H, Mahmoodzada M, Kron M, Steiner W (2008):
Organ Preserving Transoral Laser Microsurgery for Cancer of the Hypopharynx. 43. Jäckel MC, Ambrosch P, Christiansen H, Martin A, Steiner W (2008): Value of
postoperative radiotherapy in patients with pathologic N1 neck disease. Head Neck 30, 44. Tello K, Christiansen H, Gürleyen H, Dudas J, Rave-Fränk M, Hess CF, Ramadori G,
Saile B (2008): Irradiation leads to apoptosis of Kupffer cells by a Hsp27-dependant pathway followed by release of TNF-alpha. Radiat Environ Biophys 47, 389-397 45. Wagner D, Anton M, Vorwerk H, Gsänger T, Christiansen H, Poppe B, Hess CF,
Hermann RM (2008): In vivo alanine/electron spin resonance (ESR) dosimetry in radiotherapy of prostate cancer: A feasibility study. Radiother Oncol 88, 140-147 46. Nitsche M, Christiansen H, Hermann RM, Lucke EM, Peters K, Rave-Frank M,
Schmidberger H, Pradier O (2008): The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro. Int J Radiat Biol 84, 643-657 47. Vorwerk H, Wagner D, Christiansen H, Hess CF, Hermann RM (2008): An easy
irradiation technique (partial half-beam) to reduce renal dose in radiotherapy of cervical cancer including paraaortic lymph nodes. Strahlenther Onkol 184, 473-477 48. Moriconi F*, Christiansen H*, Raddatz D, Dudas J, Hermann RM, Rave-Fränk M,
Sheikh N, Saile B, Hess CF, Ramadori G (2008): Effect of radiation on gene expression of rat liver chemokines: in vivo and in vitro studies. Radiat Res 169,162-169 *equal first
authorship
49. König S, Krause P, Schmidt TK, Rave-Fränk M, Rothe H, Hermann RM, Becker H, Hess CF, Christiansen H (2008): Irradiation as preparative regimen for hepatocyte
transplantation causes prolonged cell cycle block. Int J Radiat Biol 84, 285-298 50. Hermann RM, Wolff HA, Jarry H, Thelen P, Gruendker C, Rave-Fraenk M, Schmidberger H, Christiansen H (2008): In vitro studies on the modification of low-
dose hyper-radiosensitivity in prostate cancer cells by incubation with genistein and 51. Vorwerk H, Hermann RM, Christiansen H, Liersch T, Hess CF, Weiss E (2007): A
special device (double-hole belly board) and optimal radiation technique to reduce testicular radiation exposure in radiotherapy of rectal cancer. Radiother Oncol 84, 320- 52. Hinni ML, Salassa JR, Grant DG, Pearson BW, Hayden RE, Martin A, Christiansen H,
Haughey BH, Nussenbaum B, Steiner W (2007): Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 133, 1198-1204 53. Hermann RM, Schwarten D, Fister S, Grundker C, Rave-Frank M, Nitsche M, Hille A, Thelen P, Schmidberger H, Christiansen H (2007): No supra-additive effects of
goserelin and radiotherapy on clonogenic survival of prostate carcinoma cells in vitro. Impact-Faktor: Im Jahr 2007 nicht gelistet 54. Hermann RM, Fest J, Christiansen H, Hille A, Rave-Fränk M, Nitsche M, Gründker C,
Viereck V, Jarry H, Schmidberger H (2007): Radiosensitization dependent on p53 function in bronchial carcinoma cells by the isoflavone genistein and estradiol in vitro. 55. Christiansen H, Sheikh N, Saile B, Reuter F, Rave-Fränk M, Hermann RM, Dudas J,
Hille A, Hess CF, Ramadori G (2007): X-irradiation in rat liver: consequent upregulation of hepcidin and downregulation of hemojuvelin and ferroportin-1 gene expression. 56. Rave-Fränk M, Schmidberger H, Christiansen H, Boll C, Lehmann J, Weiss E (2007):
Comparison of the combined action of oxaliplatin or cisplatin and radiation in cervical and lung cancer cells. Int J Radiat Biol 83, 41-47 57. Kortmann RD, Bongartz R, Dieckmann K, Dunst J, Flentje M, Gademann G, Christiansen H, Kamprad FH, Karstens JH, Pape H, Ruhl U, Schmidt BF, Willich N,
Schulz-Ertner D, Schwarz R, Timmermann B, Pohl F, Klingebiel T, Jurgens H, Rube C (2007): Requirements and Performance Profile of the Paediatric Radiation Oncology Working Group (APRO): Evaluation of the Present Situation and Description of Future 58. Christiansen H, Saile B, Hermann RM, Rave-Fränk M, Hille A, Schmidberger H, Hess
CF, Ramadori G (2007): Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in haemoglobin levels in primary radiotherapy for prostate cancer. J Cancer Res Clin Oncol 133, 297-304 59. Hermann RM, Horstmann O, Haller F, Perske C, Christiansen H, Hille A,
Schmidberger H, Fuzesi L (2006): Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use? Dis 60. Christiansen H, Hermann RM, Martin A, Florez R, Kahler E, Nitsche M, Hille A, Steiner
W, Hess CF, Pradier O. (2006): Long-term follow-up after transoral laser microsurgery and adjuvant radiotherapy for advanced recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 65, 1067-1074 61. Christiansen H, Koenig S, Krause P, Hermann RM, Rave-Frank M, Proehl T, Becker
H, Hess CF, Schmidberger H (2006): External-beam radiotherapy as preparative regimen for hepatocytes transplantation after partial hepatectomy. Int J Radiat Oncol 62. Christiansen H, Batusic D, Saile B, Hermann RM, Dudas J, Rave-Frank M, Hess CF,
Schmidberger H, Ramadori G (2006): Identification of genes responsive to gamma radiation in rat hepatocytes and rat liver by cDNA array gene expression analysis. 63. Pradier O*, Christiansen H*, Schmidberger H, Martin A, Jackel MC, Steiner W,
Ambrosch P, Kahler E, Hess CF (2005): Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 63, 1368-1377 *equal first authorship
64. Christiansen H, Hermann RM, Hille A, Schmidberger H, Martin A, Nitsche M, Hess CF,
Pradier O (2005): Phase I study of continuous mitomycin-C infusion in concomitant radiochemotherapy of primary inoperable advanced head and neck cancer. J Cancer 65. Hille A, Schmidberger H, Hermann RM, Christiansen H, Saile B, Pradier O, Hess CF
(2005): A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer. Int J Radiat Oncol Biol Phys 63, 1488-1493 66. Hille A, Christiansen H, Pradier O, Hermann RM, Siekmeyer B, Weiss E, Hilgers R,
Hess CF, Schmidberger H (2005): Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 181, 606-614 67. Hermann RM, Henkel K, Christiansen H, Vorwerk H, Hille A, Hess CF, Schmidberger
H (2005): Testicular dose and hormonal changes after radiotherapy of rectal cancer. 68. Pradier O, Lederer K, Hille A, Weiss E, Christiansen H, Schmidberger H, Hess CF
(2005): Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter. J Cancer Res Clin Oncol 131, 261-269 69. Christiansen H, Saile B, Neubauer-Saile K, Tippelt S, Rave-Frank M, Hermann RM,
Dudas J, Hess CF, Schmidberger H, Ramadori G (2004): Irradiation leads to susceptibility of hepatocytes to TNF-alpha mediated apoptosis. Radiother Oncol 72, 70. Christiansen H, Hermann RM, Hille A, Weiss E, Nitsche M, Martin A, Hess CF, Pradier
O (2004): Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C. Head Neck 26, 845-853 71. Hille A, Rave-Frank M, Pradier O, Damm C, Dorr W, Jackel MC, Christiansen H, Hess
CF, Schmidberger H (2003): Effect of keratinocyte growth factor on the proliferation, clonogenic capacity and colony size of human epithelial tumour cells in vitro. Int J 2. Übersichtsarbeiten, Fallberichte, Leserbriefe
(insgesamt 23 Publikationen, davon 15 als verantwortlicher Erst- oder Letztautor,
kumulativer Impact-Faktor [gelistete Journale]: 49,595;
durchschnittlicher Impact-Faktor [gelistete Journale]: 3,100;
die angegebenen Impact-Faktoren beziehen sich jeweils auf das Jahr des Erscheinens,
bei den Arbeiten aus 2011 ist der Impact-Faktor von 2010 angegeben)
1. Wolff HA, Vienken CRM, Christiansen H (2011): Risiko für Dritt- und Viert-Malignome
im Kopf- Hals-Bereich signifikant höher als nach Behandlung des Primärtumors für einen Zweittumor. Kommentar zu: Leon X, Martınez V, Lopez M, et al.: Risk of third and fourth tumors in patients with head and neck cancer. In: Head Neck 2010;32:1467-72. 2. Herrmann MKA, Bloch E, Overbeck T, Koerber W, Wolff HA, Hille A, Vorwerk H, Hess CF, Muller M, Christiansen H*, Pradier O* (2011): Mediastinal radiotherapy after
multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC – treatment results after long term follow-up and literature overview Cancer Radiother 15, 81-88 *equal senior authorship
3. Christiansen H, Moriconi F, Rave-Fränk M, Malik IA, Hess CF, Ramadori G (2011): In
regards to: Radiation-induced liver fibrosis is mitigated by gene therapy inhibiting transforming growth factor-beta signalling in the rat by Shi-Suo Du et al. (International Journal of Radiation Oncology Biology and Physics 2010;78:1513-1523). Int J Radiat 4. Christiansen H, Rödel RMW, Matthias C, Hess CF, Wolff HA (2010): In regards to:
Concurrent Chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: Is more always better? by Maroie Barkati et al. (International Journal of Radiation Oncology Biology and Physics 2010;76:410-416). Int 5. Christiansen H, Wolff HA, Rödel RMW, Matthias C, Hess CF (2010): In regards to:
Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma by N. Lance Downing al. (International Journal of Radiation Oncology Biology and Physics 2009;75:1064-1070). Int J Radiat Oncol Biol Phys 76, 1600-1601 6. Christiansen H, Moriconi F, Rave-Fränk M, Cameron S, Batusic D, Wagner D, Malik I,
Hess CF, Ramadori G (2010): Wirkung ionisierender Strahlung auf die Leber: Klinischer Hintergrund und experimentelle Daten. DZKF 3/4-2010, 66-75 Impact-Faktor: Im Jahr 2010 nicht gelistet 7. Christiansen H, Wolff HA, Knauth J, Hille A, Vorwerk H, Engelke C, Rödel R, Laskawi
R (2009): Radiatio – Therapieoption bei therapierefraktärer Speichelfistel. eHNO 57, 8. Christiansen H, Wolff HA, Rödel RMW, Steiner W, Matthias C, Hess CF (2009): In
Recommendations — A Consensus Panel Summary by Jean-Louis Lefebvre and K. Kian Ang, Larynx Preservation Consensus Panel (International Journal of Radiation Oncology Biology and Physics 2009;73:1293-1303). Int J Radiat Oncol Biol Phys 75, 9. Christiansen H, Hermann RM, Rothe H, Liersch T (2009): Die Infiltration des CRM
bestimmt entscheidend die Prognose. Journal Club Rektumkarzinom zu: Nagtegaal ID, Quirke P: What is the role for the circumferential margin in the modern treatment of rectal cancer? In: J Clin Oncol. 2009;26:303-12. In|Fo|Onkologie 12, 32-34 Impact-Faktor: Im Jahr 2009 nicht gelistet 10. Christiansen H, Hermann RM, Rothe H, Liersch T (2008) Welche Rolle spielt der
zirkumferentielle Resektionsrand nach präoperativer multimodaler Therapie beim lokal fortgeschrittenen Rektumkarzinom? Kommentar zu: Nagtegaal ID, Quirke P: What is the role for the circumferential margin in the modern treatment of rectal cancer? In: J Clin Oncol. 2008;26:303-12. Strahlenther Onkol 184, 693-694 11. Christiansen H (2008): Neue Substanzen in der Radioonkologie. Forum 23, 40-43
Impact-Faktor: Im Jahr 2008 nicht gelistet 12. Hermann RM, Müller-Dornieden A, Oberschmid B, Christiansen H, Rüschoff J (2007):
Microsatellite instability and DNA-mismatch repair deficiency in consequence of hereditary nonpolyposis colorectal cancer syndrome are not associated with familial adenocarcinoma of the esophagus: report on two brothers. Case Rep Clin Pract Rev 8, Impact-Faktor: Im Jahr 2007 nicht gelistet 13. Christiansen H, Hess CF (2007): Comment by H. Christiansen and C. F. Hess on G.
Studer et al. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT in Strahlenther Onkol 2007;183:411-23 (Nr. 8). Strahlenther Onkol 183, 424-425 14. Hermann RM, Christiansen H, Hess CF, Emons G, Schmidberger H (2006):
Kommentar zu U.R. Kleeberg: Tamoxifen nach und nicht simultan zur Strahlentherapie in: Strahlenther Onkol 2006;182;185-6 (No.3, „Literatur kommentiert“). Strahlenther 15. Christiansen H, Pradier O, Martin A, Steiner W, Hess CF (2006): In reply to Drs.
Cengiz et al. Int J Radiat Oncol Biol Phys 65, 955-956 16. Nitsche M, Prinz M, Hermann RM, Christiansen H, Weiss E (2005): Paraganglioma of
the cerebellum: case report and review of the literature. Int J Clin Oncol 10, 447-452 Impact-Faktor: Im Jahr 2005 nicht gelistet 17. Nitsche M, Hermann RM, Christiansen H, Berger J, Pradier O (2005): Rationale for
individualized therapy in Sinonasal Teratocarcinosarcoma (SNTC): case report. 18. Christiansen H, Hermann RM, Martin A, Nitsche M, Schmidberger H, Pradier O (2005):
Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature. Strahlenther Onkol 181, 355-362 19. Weiss E, Vorwerk H, Keall PJ, Pradier O, Christiansen H, Hille A, Hess CF (2005):
Letter to the editor concerning Senan et al., [Radiother Oncol 2004;71:139-146]. 20. Christiansen H, Hermann RM, Pradier O, Martin A, Schmidberger H (2005): Adjuvant
radiotherapy after surgical resection led to long term survival in multiple recurrent chondrosarcoma of the larynx. Case Rep Clin Pract Rev 6, 65-68 Impact-Faktor: Im Jahr 2005 nicht gelistet 21. Pradier O, Christiansen H, Ambrosch P, Kron M, Schmidberger H, Hess CF (2004): A
long-term follow-up study after split-course irradiation with concurrent chemotherapy (carboplatin) for locally advanced head and neck cancer and a review of the literature. ORL J Otorhinolaryngol Relat Spec 66, 325-331 22. Hermann RM, Fuzesi L, Pradier O, Christiansen H, Schmidberger H (2004): Presence
of human papillomavirus-18 and Epstein-Barr virus in a squamous cell carcinoma of the tongue in a 20-year-old patient. Case report and review of the current literature. Cancer Impact-Faktor: Im Jahr 2004 nicht gelistet 23. Hermann RM, Christiansen H, Schmidberger H, Hess CF, Pradier O (2004): Comment
on 'Dieckmann K, Georg D, Zehetmayer M, Bogner J, Georgopoulos M, Potter R. LINAC based stereotactic radiotherapy of uveal melanoma: 4 years clinical experience.' [Radiother Oncol. 2003;67(2):199-206]. Radiother Oncol 70, 211

Source: http://www.strahlentherapie-goettingen.de/media/pdf/christiansen_publikationen.pdf

Boys2men-proposal

Boys to Men? The Crisis in Teenage Masculinity Caught between a macho past and a feminist future, adolescent boys are not being initiated and mentored into rounded, emotionally expressive, mature masculinity. The stories of these boys will show why, and point out what needs to be done. Introduction Boys To Men? The Crisis in Teenage Masculinity A Film By Frederick Marx

Dpa.doc

PAGE 1 OF 2 DURABLE POWER OF ATTORNEY THE PURPOSE OF THIS POWER OF ATTORNEY IS TO GIVE THE PERSON YOU DESIGNATE (YOUR “AGENT”) BROAD POWERS, WHICH MAY INCLUDE POWERS TO MAKE DECISIONS RELATING TO YOUR HEALTH CARE, WITHOUT ADVANCE NOTICE TO YOU OR APPROVAL BY YOU. THIS POWER OF ATTORNEY DOES NOT IMPOSE A DUTY ON YOUR AGENT TO EXERCISE GRANTED POWERS, BUT WHEN POWERS A

Copyright © 2010 Health Drug Pdf